Central tolerance is the immune system’s quality-control process, carried out mainly in the thymus, that eliminates or neutralizes immune cells capable of attacking the body’s own tissues. It is the reason most people go through life without their T cells turning on their own organs. When it works well, you never notice it. When it fails, the consequences range from organ-specific autoimmune diseases to severe multi-organ syndromes. The process is more intricate than a simple pass/fail screening, and understanding how it operates, where it has blind spots, and why it deteriorates with age sheds light on autoimmune disease in ways that matter for real patients.
The Thymus as a Training Ground
The thymus, a small organ behind the breastbone, is where immature T cells go through an intensive audition. Its internal structure is divided into two main zones: the cortex and the medulla. Each region is lined with specialized thymic epithelial cells that serve as instructors and examiners for developing T cells. These epithelial cells come in cortical and medullary varieties, are derived from a common precursor, and go through their own staged development before they can support T cell maturation.1PubMed Central. Thymic epithelial cell development and its dysfunction in human diseases Recent ultrastructural work in mice has identified at least 11 distinct types of thymic epithelial cells, four in the cortex and seven in the medulla, each with unique physical features suggesting they contribute differently to the various stages of T cell education.2PubMed. Mapping murine thymic epithelial cells: functional ultrastructure and implications for thymopoiesis
The process works in two broad stages. In the cortex, T cells that can recognize molecules displayed on other cells at all are kept alive. Those that cannot are discarded, because a T cell that cannot interact with the body’s cell-surface molecules is useless for detecting infections. This first step is called positive selection. T cells that pass then migrate to the medulla for a much harder test: negative selection. Here, the question flips. T cells that react too strongly to the body’s own molecules are flagged as dangerous and eliminated, because a cell that attacks self-tissue is worse than useless. The fate of each developing T cell hinges on how strongly its receptor interacts with self-molecules displayed by the thymus’s antigen-presenting cells.3PubMed Central. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see)
How the Thymus Knows What Your Pancreas Looks Like
Here is the puzzle that makes central tolerance remarkable. The thymus is a small organ in your chest. Your insulin-producing cells are in the pancreas. Your thyroid proteins are in the neck. How does the thymus know what molecules are present in distant organs so it can test T cells against them? The answer is a gene called AIRE, short for Autoimmune Regulator. AIRE drives medullary thymic epithelial cells to produce a wide sampling of proteins that are normally found only in specific peripheral tissues.4PubMed Central. AIRE in the thymus and beyond In essence, AIRE turns on genes that a thymic cell would never otherwise express, creating a molecular catalog of what “self” looks like across the whole body.
This process, sometimes called promiscuous gene expression, means a medullary epithelial cell might display bits of insulin, thyroid hormone precursors, or retinal proteins, all at once. Any developing T cell that reacts strongly to these displayed self-molecules gets deleted. Experiments in mice have shown this directly: when AIRE fails to drive expression of a specific tissue antigen in the thymus, that antigen becomes a target for autoimmune attack in the body.5PubMed Central. Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity
AIRE does not work alone. A second transcription factor, Fezf2, drives expression of a partly overlapping but distinct set of tissue-specific genes. Together, AIRE and Fezf2 shape the range of self-molecules that medullary epithelial cells can present, including those displayed by specialized subpopulations sometimes called thymic mimetic cells, which resemble cells from other organs.6PubMed. Aire and Fezf2 Shape the Medullary Thymic Epithelial Cell Immunopeptidome for Central Tolerance The result is a surprisingly thorough preview of the body’s own molecular landscape, all contained within a few centimeters of thymic tissue.
Dendritic Cells Bring News from Outside
Thymic epithelial cells are not the only antigen-presenting cells involved. Dendritic cells, a class of immune cells specialized in collecting and displaying molecular fragments, play a complementary role. Some dendritic cells reside permanently in the thymus, particularly in the medulla, where they pick up tissue-specific antigens produced by the epithelial cells around them and present those antigens to developing T cells.7PubMed Central. The Role of Dendritic Cells in Central Tolerance
Other dendritic cells migrate into the thymus from the periphery, carrying antigens they have collected from tissues elsewhere in the body. Still others capture circulating molecules directly from the blood that flows through the junction between the thymus’s cortex and medulla. This means the thymus receives antigen intelligence from multiple routes: its own epithelial cells making tissue proteins via AIRE and Fezf2, resident dendritic cells repackaging those proteins, and incoming dendritic cells ferrying in molecules from distant tissues and even from sites of inflammation.8PubMed Central. Thymic Dendritic Cells Revisited Together, these overlapping systems make the thymic screening process far more comprehensive than any single mechanism could achieve on its own.
Deletion Is Not the Only Option
The most dramatic outcome of negative selection is apoptosis: the self-reactive T cell dies. This process, called clonal deletion, depends on specific cell-death proteins. One of the most important is Bim, a molecule that triggers cell death from inside the cell. In mice engineered to lack Bim, T cells that should have been deleted instead survive. Researchers have used this trick to actually count how many T cells are normally eliminated by clonal deletion, generating mice lacking Bim alongside a fluorescent marker that lights up when a T cell receives the signal to die.9PubMed Central. Murine thymic selection quantified using a unique method to capture deleted T cells When both Bim and a related death receptor called Fas are disrupted, mice develop late-onset autoimmunity, underscoring that these cell-death pathways are genuine safeguards against self-reactivity.10PubMed. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction
But killing is not the thymus’s only trick. Some T cells that recognize self-molecules are redirected rather than destroyed. If a developing T cell interacts with self-antigen at a moderately high level, somewhere between the strength that triggers deletion and the weakness that leads to neglect, it can be diverted into becoming a regulatory T cell. Regulatory T cells are the immune system’s peacekeepers: they actively suppress other immune cells that might otherwise attack healthy tissue. Research has identified at least two distinct developmental pathways for thymic regulatory T cells, one of which co-opts the molecular machinery of negative selection itself, while the other more closely resembles positive selection.11PubMed Central. Thymic regulatory T cells arise via two distinct developmental programs Both routes produce cells that patrol the body suppressing autoimmune responses, effectively providing a second line of defense when deletion misses a few self-reactive escapees.
B Cells Have Their Own Version
Central tolerance is not exclusive to T cells. B cells, the immune cells responsible for producing antibodies, undergo their own screening in the bone marrow. Immature B cells whose receptors bind strongly to self-molecules face two possible fates: clonal deletion, similar to what happens in the thymus, or receptor editing, a process in which the B cell rearranges its antibody genes to try to produce a receptor that no longer recognizes self. Studies in mice suggest that central tolerance and receptor editing affect a large fraction of developing B cells, and that escape by simply switching to a different antibody gene is not common enough to be a major loophole.12PubMed Central. Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape
Single-cell antibody analysis in humans has revealed that defects in B cell central tolerance are present in several autoimmune diseases and in certain immunodeficiency conditions caused by single gene mutations.13PubMed Central. Mechanisms of central tolerance for B cells This matters because autoimmune diseases often involve both self-reactive T cells and self-reactive antibodies. A breakdown in one tolerance compartment can compound a weakness in the other.
What APECED Teaches Us About Failure
The strongest proof that central tolerance prevents autoimmune disease comes from people who lack it. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, known as APECED, is a rare inherited disorder caused by mutations in the AIRE gene.14PubMed. APECED mutations in the autoimmune regulator (AIRE) gene Patients with APECED inherit defective copies of AIRE from both parents, and the consequences are severe: their thymic epithelial cells fail to display the normal range of tissue-specific antigens, so self-reactive T cells escape into the body unchecked.15PubMed Central. Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients
The result is autoimmune destruction of multiple organs, often starting in childhood. Patients typically develop chronic yeast infections, hypoparathyroidism, and adrenal insufficiency, but the disease can also attack the thyroid, liver, ovaries, and other tissues. The pattern of which organs are affected varies from person to person, reflecting which tissue-specific antigens AIRE would have displayed in a healthy thymus. APECED is rare, but it serves as a natural experiment demonstrating that without AIRE-driven central tolerance, the immune system turns on its host in a predictable and devastating way.
Why Central Tolerance Gets Worse with Age
The thymus does not stay the same size or activity level throughout life. It begins shrinking, a process called involution, starting around puberty and continuing steadily into old age. The functional tissue gets progressively replaced by fat, and the number and proportion of medullary thymic epithelial cells decline along with expression of tissue-restricted antigens.16PubMed Central. Central tolerance is impaired in the middle-aged thymic environment The practical consequence is that the thymus becomes less effective at weeding out self-reactive T cells.
Research using mouse models of accelerated thymic involution has found that shrinkage of the thymus leads to a measurable release of autoreactive T cells, accompanied by chronic inflammation including cellular infiltration into non-lymphoid tissues and elevated inflammatory signaling molecules. The failure appeared to stem primarily from decreased AIRE expression rather than from problems with regulatory T cell production.17PubMed Central. Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation Studies using thymic tissue slices from middle-aged mice have confirmed that the aging thymic environment does not support efficient negative selection or regulatory T cell induction, even for thymocytes reacting to commonly expressed self-antigens.16PubMed Central. Central tolerance is impaired in the middle-aged thymic environment
This age-related decline in central tolerance likely contributes to the well-known increase in autoimmune phenomena and chronic low-grade inflammation (sometimes called “inflammaging”) in older adults. The thymus is not the only factor, but it appears to be a significant and underappreciated one.
Blind Spots That Central Tolerance Cannot Cover
Even a perfectly functioning thymus cannot screen for every possible self-antigen. One important gap involves post-translational modifications, the chemical changes that proteins undergo after they are made. Many of the body’s proteins are modified by the addition of sugar groups, phosphate groups, or other chemical tags. These modifications can alter the shape of a protein enough that it looks like a foreign target to the immune system. Research in a mouse model of rheumatoid arthritis showed that T cells specific for the unmodified version of collagen type II were efficiently eliminated by central tolerance, but T cells recognizing the modified version, which is actually the dominant form in the body’s joints, escaped thymic screening entirely.18PubMed Central. T cells specific for post-translational modifications escape intrathymic tolerance induction
The implication is striking. The thymus displays the gene-encoded version of a protein, but the version circulating in your tissues may carry chemical modifications the thymus has never shown to developing T cells. Since the majority of the body’s proteins undergo some form of post-translational modification, this represents a systematic blind spot. It may partly explain why autoimmune diseases often target modified forms of self-molecules, a pattern seen in rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.
Another gap involves signal strength. T cells whose receptors bind self-antigens weakly, with low avidity, can slip past both central and peripheral tolerance mechanisms. Research has shown that while T cells with high-avidity binding to a tissue-restricted antigen are efficiently eliminated in the thymus, low-avidity T cells survive and can go on to cause autoimmune damage in the periphery.19PubMed Central. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity These low-avidity escapees may be activated later in life by infections, tissue damage, or changes in the inflammatory environment that effectively amplify a weak self-reactive signal into a damaging response.
Tolerance Begins Before Birth
Central tolerance is active during fetal development, and fetal T cells have a distinctive bias toward becoming regulatory T cells. Fetal immune cells show a strong predisposition to differentiate into regulatory T cells that promote tolerance to self-antigens. This tolerogenic bias also extends to non-inherited antigens: small numbers of maternal cells cross the placenta and reside in fetal tissues, a phenomenon called maternal microchimerism. Rather than attacking these foreign maternal cells, the fetal immune system tolerates them.20PubMed Central. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease
Maternal microchimerism appears to actively shape the fetal regulatory T cell population. In both mice and humans, maternal microchimeric cells in fetal tissues have been directly correlated with the presence of regulatory T cells specific to the mother’s unique molecular markers.21PubMed Central. Microchimerism: tolerance vs. sensitization This is fascinating because it means the fetus does not just tolerate its own tissues; it also learns to tolerate its mother’s cells, which will persist in small numbers throughout life. Some researchers have speculated that this early tolerance education may influence transplant outcomes later in life, since people sometimes show enhanced tolerance to organs from family members who share the mother’s tissue type.
Viral Threats to the Thymus
Viruses that infect the thymus can directly disrupt central tolerance. During the COVID-19 pandemic, researchers found that patients with severe disease showed reduced thymic function, and the degree of reduction correlated with disease severity. SARS-CoV-2 enters cells through a receptor called ACE2, and this receptor turned out to be expressed on thymic epithelial cells, particularly the medullary epithelial cells responsible for displaying self-antigens during negative selection. The virus was shown to target these cells and downregulate genes critical for their adhesion and survival.17PubMed Central. Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation This finding may help explain the wave of new-onset autoimmune conditions reported after severe COVID-19 infections, though establishing a definitive causal link requires more research.
SARS-CoV-2 is not unique in this regard. HIV is well known to devastate the thymus, particularly in children. Other viruses, chemotherapy, and radiation exposure can all damage thymic epithelial cells and impair the organ’s ability to screen T cells properly. Any insult that reduces the number or function of medullary epithelial cells functionally mimics the effect of accelerated aging on the thymus: fewer self-antigens displayed, less effective screening, more self-reactive T cells escaping into circulation.
An Ancient System Shared Across Vertebrates
Central tolerance is not a recent evolutionary invention. Research in zebrafish has demonstrated that the molecular machinery for active self-tolerance, including regulatory T cell equivalents expressing the Foxp3 gene, was already present early in vertebrate evolution. These fish possess the molecular potential for adaptive autoimmunity, meaning their immune system could theoretically attack self, but they simultaneously have active regulatory mechanisms to prevent it.22PubMed Central. Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish The implication is that as soon as vertebrates evolved an adaptive immune system powerful enough to cause autoimmune damage, they also evolved the tolerance mechanisms needed to keep that power in check. The two capabilities appear to have co-evolved as a package deal, which makes sense: an immune system without tolerance is a weapon without a safety catch.
Engineering Tolerance From Scratch
Damage to the thymus, whether from aging, infection, or cancer treatment, is difficult to reverse because thymic epithelial cells have limited regenerative capacity, and scientists have struggled to grow them in the lab. Current research efforts include bioengineered thymus organoids, lab-built structures that mimic the thymic microenvironment and could potentially be used to restore T cell education in people whose thymus has been destroyed or severely compromised.23PubMed Central. Restoration of Thymus Function with Bioengineered Thymus Organoids A functional artificial thymus could have applications beyond autoimmune disease. In organ transplantation, the central problem is that the recipient’s immune system attacks the donor organ as foreign. If you could educate the recipient’s T cells to tolerate the donor’s tissue type, through a bioengineered thymus seeded with the donor’s cells, you might eliminate the need for lifelong immunosuppressive drugs. That goal remains distant, but the underlying science is advancing steadily as the cellular requirements for thymic function become better understood.
Meanwhile, a different therapeutic approach targets central tolerance indirectly. Several experimental treatments aim to boost regulatory T cell numbers or function in patients with autoimmune diseases, effectively reinforcing the same tolerance mechanism that the thymus generates naturally. Others attempt to mimic the AIRE-driven antigen display process using nanoparticles or engineered cells that present self-antigens to the immune system in a tolerogenic context. None of these approaches has yet reached routine clinical use, but they represent a shift in autoimmune therapy from blanket immunosuppression toward something more surgical: restoring or mimicking the specific tolerance that the thymus was supposed to establish in the first place.